Back to Trials
NCT05598398PHASE4Recruiting

NPWTi on Closure of Chronic Pressure Sores

Northwestern University

Start Date

9/26/2022

Completion Date

5/1/2027

Summary

The primary objective of this study is to assess the effectiveness of the Negative Pressure Wound Therapy system with instillation therapy (NPWTi) on closure of chronic pressure sores. This intervention will be compared to wet-to-dry dressings, which is standard of care. In this post-market, on-label study, we hope to show that the NPWTi system more effectively closes pressure sores following debridement than traditional care.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. Ischial and sacral wounds at stage 3 and 4. 2. Any pressure sore that has the potential for a good seal. Exclusion Criteria: 1. Any pressure sore that does not have potential for a good seal. 2. Patients with fecal incontinence (due to potential for pressure sore to be near the anus). 3. Patients who by the opinion of the Principal Investigator are not candidates for surgical closure (age, BMI, comorbidities, etc.). 4. Patients who are pregnant. This is standard of care for surgery anyway, and there is uncertainty of how both the surgery and intervention would affect the fetus. We therefore stress any form of birth control, abstinence, and method to prevent pregnancy for those enrolled in the study.

Interventions

DEVICE

V.A.C.Ulta™ Negative Pressure Wound Therapy System

OTHER

Standard of Care (Wet-to-dry dressings)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Pressure Sore

Locations

Northwestern University

Chicago, Illinois 60611

United States